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ABSTRACT
A number of systemic disorders increase patient susceptibility to periodontal disease, which moreover evolves more 
rapidly and more aggressively. The underlying factors are mainly related to alterations in immune, endocrine and con-
nective tissue status. These alterations are associated with different pathologies and syndromes that generate periodontal 
disease either as a primary manifestation or by aggravating a pre-existing condition attributable to local factors. This 
is where the role of bacterial plaque is subject to debate. In the presence of qualitative or quantitative cellular immune 
alterations, periodontal disease may manifest early on a severe localized or generalized basis – in some cases related 
to the presence of plaque and/or specific bacteria (severe congenital neutropenia or infantile genetic agranulocytosis, 
Chediak-Higiashi syndrome, Down syndrome and Papillon-Lefèvre syndrome). In the presence of humoral immune 
alterations, periodontal damage may result indirectly as a consequence of alterations in other systems.
In connective tissue disorders, bacterial plaque and alterations of the periodontal tissues increase patient susceptibility 
to gingival inflammation and alveolar resorption (Marfan syndrome and Ehler-Danlos syndrome).
The management of periodontal disease focuses on the control of infection and bacterial plaque by means of mecha-
nical and chemical methods. Periodontal surgery and even extraction of the most seriously affected teeth have also 
been suggested. There are variable degrees of consensus regarding the background systemic disorder, as in the case of 
Chediak-Higiashi syndrome, where antibiotic treatment proves ineffective; in severe congenital neutropenia or infantile 
genetic agranulocytosis, where antibiotic prophylaxis is suggested; and in Papillon-Lefèvre syndrome, where an establis-
hed treatment protocol is available.
Key words: Periodontal disease, systemic alterations, periodontitis due to genetic alterations, Chediak-Higiashi syndrome, 
Papillon-Lefèvre syndrome, Down syndrome, Marfan syndrome, Ehler-Danlos syndrome, severe congenital neutropenia, 
infantile genetic agranulocytosis, hyperimmunoglobulinemia E.
RESUMEN
Existen condiciones sistémicas  que generan una mayor susceptibilidad a la enfermedad periodontal, la cual evoluciona de 
forma  más rápida y agresiva. Los factores involucrados tienen relación, principalmente con  alteraciones a nivel inmunológico, 
a nivel hormonal y del tejido conectivo. Estas alteraciones se asocian a diversas patologías y síndromes, generando la enfer-
medad periodontal como una manifestación primaria o agravando una condición ya establecida por factores locales. Aquí es 
donde el papel de la placa bacteriana es discutido. Cuando existe alteración inmunológica celular cualitativa o cuantitativa, 
la enfermedad periodontal se puede presentar tempranamente de forma severa localizada o generalizada, existiendo en 
algunos casos relación a la presencia de placa y/o a bacterias específicas (neutropenia severa congénita o agranulocitosis 
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INTRODUCTION
Periodontal disease, which produces lesions in the tooth-
supporting tissues, requires a different approach when 
associated to risk factors secondary to systemic disorders. 
The alteration of the periodontal tissues may be a primary 
consequence of such systemic alterations or a secondary 
effect - causing periodontal disease to progress without any 
apparent underlying cause, or alternatively maintaining or 
incrementing the severity of a previously established local 
condition (1).
The principal causal agent of periodontal disease is bac-
terial plaque, which induces progressive tissue damage. In 
the presence of susceptibility to periodontal disease due to 
systemic conditions, the role of bacterial plaque is debated. 
Some authors consider that periodontal disease cannot be 
induced without the presence of  plaque and tartar, and 
suggest that a systemic predisposition simply accelerates 
the destruction caused by bacterial agents. Others, however, 
consider that there is no consistent evidence demonstra-
ting that nonspecific bacterial plaque causes processes of 
this kind, since no cause-effect relationship is established 
between the type of bacterial plaque and the severity of 
periodontal damage (2). 
The development and evolution of periodontal disease is 
largely dependent upon the host immune response, the in-
tegrity of the tissues, humoral and cellular immunity, and 
on certain endocrine and nutritional factors. Other factors 
have also been related to periodontal disease, such as age, 
locations within the mouth that are more susceptible to in-
fection (incisors and first molars associated to specific flora), 
and concrete bacterial species (Captosinofaga, Actinomyces 
naeslundi, Actinobacillus actinomycetemcomitans) (2).
Thus, alterations in this system increase susceptibility to 
periodontal disease, with signs of a simple or more complex 
presentation, in accordance with the existing immune alte-
ration. Furthermore, the condition may prove more severe 
in the presence of associated metabolic disorders, since the 
latter act in synergy with periodontal damage (2).
The alterations in the immune system may be located at 
cellular and/or humoral level. In this context, lymphocytes 
play a key role in immune function, and the congenital 
or acquired absence of  one or more cell lines gives rise 
to diseases that may prove fatal – such as acute leukemia 
or AIDS (2). Neutrophil alterations in turn may be of a 
qualitative (altered chemotaxis and phagocytosis) or quan-
titative nature (neutropenia, agranulocytosis), and both 
predispose to rapid and severe periodontal destruction. An 
increased vulnerability to severe periodontitis can be seen in 
Down syndrome (trisomy 21), Chediak-Higashi syndrome 
and Papillon-Lefèvre syndrome. The affected individuals 
show an increased incidence of infections attributable to 
the fact that these cells show a diminished expression of 
surface glycoproteins needed for adhesion to bacteria. In 
some cases, this kind of disorder has been associated to 
periodontal damage similar to that of generalized prepu-
beral periodontitis (2). Alterations in the humoral immune 
system, fundamentally affecting the immunoglobulins, 
generates periodontal disease when the humoral disorder 
in turn affects other systems such as cellular immunity or 
the metabolic system. Therefore, the alteration of these two 
systems is the principal mechanism underlying periodontal 
disease mediated by immunoglobulins (2). It has even been 
demonstrated that humoral response at this level is specific 
in each individual – which in turn helps explain the great 
variety of responses to periodontal treatment (3).
Other disorders, such as those associated to the connective 
tissues also increase the susceptibility to periodontal alte-
rations, and in some cases, to the presence of plaque; as 
a result, the destructive effects inherent to inflammatory 
response are exacerbated, with no adequate reparatory 
response (2).
The present study reviews the literature on periodontal 
disease associated to systemic alterations of genetic origin, 
together with the clinical manifestations associated to these 
processes. In addition, the odontologic treatment options 
of these patients are commented.
GENERAL CLINICAL CHARACTERISTICS
This group of genetic diseases has been classified according 
to the principal alteration involved, in order to better un-
derstand the most likely mechanism underlying periodontal 
disease:
infantil genética, síndrome de Chediak-Higashi, síndrome de Down y síndrome Papillon-Lefévre). En la alteración inmune 
humoral el daño periodontal, puede ser generado de forma indirecta por alteración de otros sistemas.
En los desordenes del tejido conectivo, la placa bacteriana y las alteraciones en los tejidos periodontales, aumentan la 
susceptibilidad a la inflamación gingival y resorción alveolar (síndrome de Marfan y síndrome de Ehler-Danlos)
El manejo y tratamiento de la enfermedad periodontal esta enfocado al control de la infección y  de la placa bacteriana, 
mediante métodos mecánicos y a métodos químicos. También se sugiere la cirugía periodontal e inclusive la exodoncia 
de los dientes mas afectados. Existen variantes de acuerdo a la alteración sistémica de base, como el caso del síndrome 
de Chediak-Higashi donde no responde a tratamientos antibióticos, en la neutropenia severa congénita o agranulocitosis 
infantil genética que sugiere profilaxis antibiótica y en el caso del síndrome de Papillon-Lefévre  con un protocolo es-
tablecido para el tratamiento.
Palabras clave: Enfermedad periodontal, alteraciones sistémicas, periodontitis por alteraciones genéticas, síndrome de Che-
diak-Higashi, síndrome de Papillon-Lefévre, síndrome de Down, síndrome de Marfan, síndrome de Ehler-Danlos, neutropenia 
severa congénita, agranulocitosis infantil genética, síndrome de hiperglobulinemia E.
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a) Connective tissue alterations: Marfan syndrome, Ehler-
Danlos syndrome.
b) Immune alterations: severe congenital neutropenia (SCN) 
or infantile genetic agranulocytosis or Kostmann syndro-
me (IGA), Chediak-Higiashi syndrome, Down syndrome, 
Papillon-Lefèvre syndrome, hyperimmunoglobulinemia E 
syndrome. 
In Marfan syndrome it seems that the mutation of a gene 
encoding for fibril-1 in chromosome 15 generates an altera-
tion in the synthesis of a glycoprotein forming part of the 
connective tissue matrix. This in turn generates defects in 
a series of locations such as the ocular lens suspensor liga-
ment, blood vessel walls and, apparently, the periodontal 
ligament (4). Ehler-Danlos syndrome in turn is characteri-
zed by extensible skin, hypermobile joints, tissue fragility 
and, at oral level, persistent hyperplastic gingivitis (5).
The immune diseases contemplated in the above classifica-
tion are all primary immune deficiencies caused by a decrea-
se in neutrophil presence (SCN or IGA), or by alterations 
in the functions of these cells – as in the four above cited 
syndromes. SCN or IGA predisposes patients to bacterial 
and fungal infections in childhood, because the decrease in 
neutrophil presence alters the host defense capacity. Mo-
reover, a decrease is seen in the production of granulocyte 
colony stimulating factor (6,7). Chediak-Higiashi syndrome 
is accompanied by leukocyte alterations, fundamentally 
circumscribed to the lysosomes, which destroy melanosomes 
producing oculo-cutaneous albinism. Affected patients also 
present mental retardation, and neutropenia moreover may 
also be observed – with altered neutrophil chemotaxis asso-
ciated to recurrent chronic infections (8). Down syndrome 
or trisomy 21 is caused by a chromosomal aberration that 
generates peculiar physical characteristics, manifesting with 
mental retardation and systemic alterations. The immune 
alterations described in Down syndrome are related to leu-
kocyte function, responsible for the defensive mechanisms 
in periodontal tissues (9,10). Papillon-Lefèvre syndrome 
in turn is defined by palmoplantar erythematous hyperke-
ratosis and periodontal disease. The postulated underlying 
mechanism is a mutation of the gene encoding for catepsin 
C, which generates a lysosomal protein implicated in host 
immune response, inflammatory mediation and extracellular 
matrix function – with expression in the epithelium of the 
palms and soles, and at gingival level (11). Hyperimmuno-
globulinemia E (HE) consists of an increase in serum IgE. 
This in turn leads to a series of systemic alterations with 
involvement of the skin, facial malformations and increased 
susceptibility to staphylococcal infections (12).
CLINICAL MANIFESTATIONS OF PERIODO-
NTAL DISEASE, MECHANISMS AND ASSOCIA-
TED FACTORS
The mechanism underlying periodontal disease in the group 
of syndromes characterized by connective tissue alterations 
is explained by the fact that anomalies at this level generate 
increased susceptibility to periodontal inflammation and 
bone resorption (4). Despite the existence of a common 
background alteration, the manifestations of periodontal 
disease may differ in each of the syndromes. In the case of 
Marfan syndrome, periodontitis manifests in a chronic and 
severe form with patterns of both horizontal and vertical 
bone resorption, and in accordance to the presence of 
bacterial plaque. Dental mobility has been shown to be 
due to periodontitis, and is not attributable to the primary 
condition of the syndrome (4). 
In the case of Ehler-Danlos syndrome, periodontal disease 
can be associated to syndromes type I, VII, III, or IV (5). 
Only in relation to type I is a predisposition to periodontal 
disease described, while type VIII presents as early onset 
periodontitis, premature loss of permanent teeth, fragility of 
the alveolar mucosa and gingival bleeding. The postulated 
mechanism is a defect in type III collagen, present in 16% 
of the total collagen of the periodontal ligament, affecting 
the integrity of  the periodontal junction. In addition, a 
relationship has been found to Fusobacterium nucleatum, 
which is found in the active lesion sites (5).
In SCN or IGA, the decrease in the number of neutrophils 
alters the host defense capacity, causing periodontal disease 
to manifest at an early age, with gingival inflammation, 
aggressive periodontal destruction, edema, periodontal 
pouches and tooth mobility. This is similar to prepuberal 
or rapidly progressive periodontitis with premature loss of 
the deciduous teeth (6,7,13).
The periodontal condition in Chediak-Higiashi syndrome 
manifests as early onset periodontitis with premature exfo-
liation of both dentitions. The patterns of bone resorption 
may be local or generalized, and are related to the gingival 
inflammation. The disorder is associated to anaerobe flo-
ra, due to the abundant presence of  purulent processes. 
Mention has also been made of the abundant presence of 
spirochetes in the locations with inflammation and high 
proteolytic activity, which facilitates bacterial adherence. 
Addition to this situation of lysosomal alterations and de-
fective chemotaxis in neutrophils gives rise to very aggressive 
periodontitis that tends to be recurrent and is refractory to 
antibiotic treatment (9). 
Down syndrome associated to mental retardation and to 
the systemic alterations is characterized by aggressive and 
generalized periodontitis, with the subsequent destruction 
of the supporting tissues and loss of teeth at an early age. 
Eight percent of  children with Down syndrome suffer 
periodontal lesions by 12 years of age, versus only 0.5% 
of the general population of the same age (14). The pre-
valence of periodontal disease in the population with this 
syndrome ranges from 60% to 100% in young adults under 
30 years of age (9,15). To these factors we must also add 
immune deficiency, inadequate control of bacterial plaque, 
deficient masticatory function, early aging and alterations in 
dental anatomy (short roots)(15). It has been reported that 
the presence of Actinobacillus actinomicetenconcomitans 
and of Captocinofaga in bacterial plaque is associated to 
periodontitis in these individuals. These bacterial colonies 
appear at an early age and vary according to the latter – in-
creased prevalence being seen in early puberty (15,16). 
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In patients with severe mental retardation, difficulties are 
obviously found in ensuring correct autonomous tooth 
brushing and plaque control. In this context, oral hygiene is 
essential to avoid the organization of plaque and prolonga-
tion of the disease (16). Bactericidal dysfunction results from 
defective neutrophil chemotaxis, which leads to progressive 
periodontal disease as in juvenile periodontitis. Likewise, it 
has been reported that the B and T cells, and monocytes, also 
exhibit functional defects. The periodontal damage is related 
to the degree of alteration in chemotactic function. It has 
even been shown that the neutrophil chemotactic depression 
rate reaches 59% in generalized juvenile periodontitis, 44% 
to 60% in localized juvenile periodontitis, and 50% in the 
case of rapidly progressing periodontitis (9). The mechanism 
accounting for such dysfunction is related to a decrease in 
the number of cell surface receptors, and diminished levels 
of zinc and certain vitamins in serum.
Papillon-Lefèvre syndrome in turn is characterized by 
aggressive periodontal inflammation implicating the prema-
ture loss of both dentitions. The mechanisms involved are 
related not only to immune alterations but also to alterations 
in the gingival tissues and the presence of Actinobacillus 
actinomycetemcomitans (11). In hyperimmunoglobuline-
mia E syndrome an increased susceptibility to infections 
is observed – this contributing to the development of 
periodontal disease. 
The postulated mechanism in this case is a deficient host 
cellular and humoral immune response, with a decrease in 
neutrophil chemotaxis secondary to an alteration in the 
regulation of T cell cytokines. The increase in IgE leads to a 
reduction in the production of gamma-interferon, which in-
tervenes in anti-inflammatory and in bone resorption-inhibi-
ting processes. Consequently, the inflammatory and resorp-
tive phenomena are increased in these patients, giving rise to 
advanced periodontitis at an early age. Likewise, the disorder 
is related to bacteria that produce severe periodontal damage 
in adults and in pediatric immune deficiencies (P. gingivalis, 
T. denticola, E. corrodens). Contradictorily, however, this 
immune alteration induces a delay in dentition turnover, 
since the deciduous teeth exhibit scant physiological root 
resorption (12). The clinical characteristics of periodontal 
disease associated to systemic alterations of a genetic nature, 
the associated factors, and the corresponding treatment 
options are summarized in Table 1.
 
ODONTOLOGIC TREATMENT
The management of periodontal disease in these patients centers 
on the control of infection and bacterial plaque. This is done by 
chemical methods such as the use of antiseptics and antibiotics, 
and also mechanical methods such as tartar removal and the ras-
ping of affected teeth. Periodontal surgery is sometimes advised 
to improve cleaning of certain zones, and even removal of the 
most severely affected teeth has been suggested. 
Systemic disorder Type of periodontal disease Associated factors Treatment 
Marfan syndrome Chronic-sever Local factors Bacterial plaque 
Chemical and mechanical 
control of bacterial plaque 
Ehler-Danlos syndrome 
Type I: predisposes to 
localized periodontitis. 





Chemical and mechanical 
control of bacterial plaque 
Severe congenital neutropenia 
or IGA 




Chemical and mechanical 
control of bacterial plaque 
Antibiotic prophylaxis 
advised (clindamycin)  




Rigorous bacterial plaque 
control
Unresponsive to antibiotics 
Down syndrome 
Similar to juvenile 
periodontitis
Similar to early onset 
periodontitis. Severe 
Associated to external 
factors such as bacterial 
plaque.
Associated to ABAMC. 
Hormone changes 
Rigorous bacterial plaque 
control
Papillon-Lefevre syndrome Early onset, premature loss of teeth in both dentitions Associated to ABAMC 
According to protocol 
(see Table 2) 
Hyperimmunoglobulinemia E 
syndrome Generalized, advanced 
Associated to plaque (no 
relation to magnitude of 
damage)
Chemical and mechanical 
control of bacterial plaque 
Table 1. Summary of clinical manifestations of periodontal disease due to genetic alterations.
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There are variations in treatment according to the bac-
kground systemic disorder involved, as in the case of 
Chediak-Higiashi syndrome, which fails to respond to 
antibiotics; severe congenital neutropenia or IGA where an-
tibiotic prophylaxis with clindamycin is recommended; and 
Papillon-Lefèvre syndrome, where the recommendations 
center on hygiene, antibiotics and programmed extractions 
as management approach (11)(Table 2). In Down syndrome, 
the immune defect with alterations in chemotaxis, defects 
in neutrophil phagocytosis, and the consequent production 
of free oxygen radicals pose no threat to patient respon-
se to conventional treatments (10). As postulated in the 
recent literature, the results of surgical and non-surgical 
periodontal treatments are related to control of the bacterial 
plaque, which can be maintained either by the patient or 
by the caretakers (17,18). As maintenance treatment, rein-
forcement of the tooth brushing technique is advised, with 
regular plaque removal and rigorous oral examination to 
control and maintain healthy and stable periodontal tissue 
status (10).
When dealing with periodontal problems, it is advisable 
to establish a differential diagnosis of periodontal disease 
due to systemic conditions (18), considering the individual 
factors that produce the clinical manifestations. In this 
context, it must be taken into account that response to 
treatment is not always as expected, and that sometimes 
the progression of periodontal disease is inevitable despite 
adequate maintenance treatment (19).
 
REFERENCES
1. Bullon-Fernandez P, Machuca-Portillo G. Tratamiento odontológico 
en pacientes especiales. Madrid: Edita Laboratorios Normon; 2004. p. 
131-8.
2 .Wilton JMA, Griffiths GS, Curtis MA, Maiden MFJ, Gillett IR, Wilson 
DT, et al. Detection of high-risk groups and individuals for periodontal 
diseases. J Clin Periodontol 1988;15:339-46.
3. Kinane DF, Lappin DF. Immune processes in periodontal disease: A 
review. Ann Peridontol 2002;7:62-71.
4. Straub AM, Grahame R, Scully C, Tonetti MS. Severe periodontitis in 
Marfan’s Syndrome: A Case Report. J Periodontol 2002;73:823-6.
5. Perez LA, Al-Shammari KF, Giannobile WV, Wang H. Treatment of 
periodontal disease in a patient with Ehlers-Danlos Syndrome. A Case 
Report and literature review. J Periodontol 2002;73:564-70.
6. Hakki SS, Aprikyan AAG, Yildirim S, Aydinbelge M, Gokalp A, 
Ucar C, et al. Periodontal status in two siblings with Severe Congenital 
Neutropenia: Diagnosis and Mutacional Analisis of the Cases. J Perio-
dontol 2005;76:837-44.
7. Saglam F, Atamer T, Oman U, Soidinç M, Kiraç K. Infantile Genetic 
Agranulocitosis (Kostmann Type). A Case Report. J Periodontol 1995; 
66:808-10.
8. Delcourt-Debruyne EMC, Boutigny HRA, Hildebrand HF. Features of 
severe periodontal disease in a teenager with Chediak-Higashi Syndrome. 
J Periodontol 2000;71:816-24.
9. Izumi Y, Sugiyama S, Shinozuka O, Yamazaki T, Ohyama T, Ishikawa 
I. Defective neutrophil chemotaxis in Down’s Syndrome patients and its 
relationship to periodontal destruction. J Periodontol 1989;60:238-41.
10 Zaldivar-Chiapa RM, Arce-Mendoza AY, De La Rosa-Ramírez M, 
Caffesse RG, Solis-Soto JM. Evaluation of  surgical and non-surgical 
periodontal therapies, and immunological status, of young Down’s Sín-
drome patients. J Periodontol 2005;76:1061-5.
11. Ullbro C, Brown A, Twetman S. Preventive periodontal regimen in 
Papillon-Lefevre Syndrome. Pediatr Dent 2005;27:226-32.
12. Tsang P, Derkson G, Priddy R, Junker AK, Slots J, Larjava H. Severe 
periodontitis in a 5-years-old girl with hiperimmunoglobulin E Syndrome. 
Pediatr Dent 2005;27:68-73.
13. Carlsson G, Wahlin YB, Johansson A, Olsson A, Eriksson T, Claesson 
R et al. Periodontal disease in patients from the original Kostmann family 
with severe congenital neutropenia. J Periodontol 2006;77:744-51.
14.  Borea G, Magi M, Mingarelli R, Zamboni C. The oral cavity in Down 
syndrome. J Pedodont 1990;14:139-40.
15. Amanao A, Kishima T, Akiyama S, Nakagama I, Hamada S, Morisaki 
I. Relationship of periodontopathic bacteria with early-onset periodontitis 
in Down’s Syndrome. J Periodontol 2001;72:368-73.
16. Amanao A, Kishima T, Akiyama S, Nakagama I, Hamada S, Mo-
risaki I. Periodontopathic bacteria in children with Down Syndrome. J 
Periodontol 2000;71:249-55.
17. Emingil G, Atilla G, Sorsa T, Savolainen P, Baylas H. Effectiveness 
of  adjunctive low-dose doxycycline therapy on clinical parameters 
and gingival crevicular fluid laminin-5 gamma2 chain levels in chronic 
periodontitis. J Periodontol 2004;75:1387-96.
18.  Sollecito TP, Sullivan KE, Pinto A, Stewart J, Korostoff J. Condiciones 
sistémicas asociadas con periodontitis en la infancia y la adolescencia. 
Una revisión de las posibilidades diagnósticas. Med Oral Patol Oral Cir 
Bucal 2005;10:142-50.
19. Diz P, Ocampo A, Fernández J. Alteraciones cuantitativas y funcionales 
de los neutrófilos. Med Oral 2002;7:206-21.
Deciduous dentition Permanent dentition
Instructions for oral hygiene and prophylaxis every three months 
Extraction of teeth with advanced periodontal disease. 
Extraction of all deciduous teeth 6 months before 
eruption of permanent first molars. 
Two weeks of antibiotic treatment to avoid 
complications after extractions 
0.2% chlorhexidine rinses twice a day. 
Teeth with moderate periodontal disease (bone loss < 
30% of root length, periodontal pouch depth < 5 mm): 
ultrasound and dental prophylaxis once a months, 
systemic antibiotics for 4 weeks. 
Recommended antibiotic treatment:  
amoxicillin or amoxicillin + clavulanate 20-50 
mg/kg/day or 20-40 mg/kg/day, respectively divided 
into doses every 8 hours. 
Recommended antibiotic treatment:  
amoxicillin 20-50 mg/kg/day + metronidazole (15-35 
mg/kg/day) divided into doses every 8 hours. 
Table 2. Standardized odontologic management protocol in patients with Papillon-Lefèvre syndrome (11).
